Differences in Vessel Healing Following Delivery of Everolimus or Paclitaxel: A Comparative Experimental Study Using Identical Stent and Biodegradable Polymer Platforms

EuroIntervention - France
doi 10.4244/eijv10i6a125
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Europa Digital & Publishing

Related search

Everolimus-Eluting Stent Platforms in Percutaneous Coronary Intervention: Comparative Effectiveness and Outcomes

Medical Devices: Evidence and Research
MedicineBiomedical Engineering
2015English

Biodegradable Polymer-Coated Thin Strut Sirolimus-Eluting Stent vs. Durable Polymer-Coated Everolimus-Eluting Stent in the Diabetic Population

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2013English

Safety and Efficacy of Biodegradable Polymer-Coated Thin Strut Sirolimus-Eluting Stent vs. Durable Polymer-Coated Everolimus-Eluting Stent in Patients With Acute Myocardial Infarction

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2018English

Two-Year Vessel Healing After Everolimus-Eluting Stent Implantation: Serial Assessment by Optical Coherence Tomography

Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Biodegradable Polymer Evermine 50™ Everolimus Eluting Coronary Stent System With Ultrathin (50 Μm) Strut

Integrative Clinical Medicine
2018English

Damage to Polymer of Paclitaxel-Eluting Stent

Circulation Journal
MedicineCardiovascular MedicineCardiology
2008English

Randomised Comparison of a Biodegradable Polymer Ultra-Thin Sirolimus-Eluting Stent Versus a Durable Polymer Everolimus-Eluting Stent in Patients With De Novo Native Coronary Artery Lesions: The meriT-V Trial

EuroIntervention
MedicineCardiovascular MedicineCardiology
2018English

Preliminary Clinical Outcomes After Implantation of Newer-Generation Biodegradable Polymer-Coated Everolimus-Eluting Stent in “Real-World” Patients With Coronary Artery Disease

World Journal of Cardiovascular Diseases
2016English

Biodegradable-Polymer Biolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study

Texas Heart Institute Journal
MedicineCardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy